Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 109
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00006371 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | ||
| NCT03404635 | Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism | ||
| NCT02249923 | Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry | ||
| NCT02756247 | A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma | ||
| NCT03899155 | Pan Tumor Rollover Study | ||
| NCT02422797 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2) | ||
| NCT06396533 | Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) | ||
| NCT06107738 | Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma | ||
| NCT03450057 | Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment | ||
| NCT02745054 | Safety of Oral Anticoagulants Registry | ||
| NCT04162366 | A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease. | ||
| NCT06083922 | A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) | ||
| NCT03522259 | Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery | ||
| NCT06232551 | Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism | ||
| NCT01641367 | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure | ||
| NCT02172872 | "InDACtion" vs "3+7" Induction in AML | ||
| NCT03823924 | Changes in Body Composition Under Ustekinumab in PsA | ||
| NCT05285137 | Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects | ||
| NCT03236428 | Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT06066346 | A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy | ||
| NCT02938520 | Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants | ||
| NCT02867020 | Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels | ||
| NCT01236391 | Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL) | ||
| NCT05523089 | The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults | ||
| NCT04089345 | Stelara fOr ChRonic AntibioTic rEfractory pouchitiS | ||
| NCT05629052 | TrEatment Approach in the Multimodal Era Registry | ||
| NCT05117931 | A Study of Amivantamab in People With Esophagogastric Cancer | ||
| NCT04399551 | A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries | ||
| NCT02207062 | Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma | ||
| NCT03696160 | The Late Presenter Treatment Optimisation Study | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT06856902 | BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT01947920 | A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers | ||
| NCT04371380 | Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants | ||
| NCT04240210 | Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) | ||
| NCT02772588 | AASUR in High Risk Prostate Cancer | ||
| NCT03063203 | Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia | ||
| NCT03503344 | Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer | ||
| NCT04394936 | An Explorative Psoriasis Biomarker Study | ||
| NCT07488156 | Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder | ||
| NCT02373930 | Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects | ||
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | ||
| NCT00855413 | HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine | ||
| NCT02478632 | Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen | ||
| NCT04268498 | A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma | ||
| NCT02951052 | Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults | ||
| NCT06549634 | Biomarkers of AKI in Patients Receiving Daratumumab | ||
| NCT03290950 | A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma |
